Academy of Pharmaceutical Sciences

Slides:



Advertisements
Similar presentations
A Health and Wellbeing Board for Leicestershire Cheryl Davenport Programme Director.
Advertisements

NIHR Delivering Better Health Through Training Researchers 19 September 2011 Dr David Cox Deputy Director – Research Faculty.
NIHR Delivering Better Health 20 November 2012, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
MASFAA Strategic Plan Mission Statement The Massachusetts Association of Student Financial Aid Administrators empowers its members to be educated,
Changes to the Educational Landscape: an SHA perspective Tricia Ellis, Head of Knowledge Management and eLearning South West Technology Enhanced Learning.
A Proposal Dr Susan Hamer
West Midlands Academic Health Science Network
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
West Midlands Academic Health Science Network
Embedding Public Engagement Sophie Duncan and Paul Manners National Co-ordinating Centre for Public Engagement Funded by the UK Funding Councils, Research.
Housing and care options for older people in Wigan Angela Durkin, Senior Housing Policy Officer, Wigan Council John McArdle, Chief Officer, Age UK Wigan.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
David Palmer Head of Policy & Review LSP REVIEW 2013.
Public engagement and lifelong learning: old wine in a new bottle, or a blended malt? Paul Manners Director, National Co-ordinating Centre for Public Engagement.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Building Strong Library Associations Programme Programme Overview Naomi Haasbroek SCECSAL Conference, Botswana, December 2010.
Diabetes Programme Progress Report Dr Charles Gostling, Joint Diabetes Clinical Director October 2013.
Drug Discovery Exchange Fellowship Workshop 9 th -10 th December Mike Hardman IMI EMTRAIN Coordinator.
Exploring Social Enterprise EUROPEAN UNION Investing in Your Future European Regional Development Fund
Royal Society Industry Fellowships Scheme Dr Donna Lammie, Senior Manager, Grants.
NHS NW Healthcare science network Helen Liggett - NHS NW HCS workforce lead.
Mentoring Professor Elizabeth Simpson OBE FRS FMedSci Emeritus Professor of Transplantation Biology, Imperial College London Colby Benari Programme Officer,
Research by IPCP.  People, Performance and Principles – our Co- operative Difference  People / HR Forum – why another network ?  Our Co-operative Difference.
Expert Input : Review of Days 1 & 2 1. Forum Days 1 & 2 2 Overview of Days’ 1 & 2 Themes, Sessions, and Guiding Questions.
Healthy Computing Strategic Healthcare Projects Tony Horne.
Welcome to SURF 09 Involving Patients and the Public in HCAI Research.
Canadian Nuclear Society Société Nucléaire Canadienne “Supporting nuclear science and technology for 25 years” “25 ans de promotion de la science et de.
Institute of Business Consulting British Computer Society Tony Ginda Membership Manager Sabrina Ahmed Professional Development Manager 15 May 2007.
AAMC Council of Faculty and Academic Societies (CFAS) Pamela N Peterson, MD MSPH Associate Professor of Medicine Kevin Lillehei, MD Professor and Chair,
Medicines Optimisation Tony Jamieson Clinical Lead for Medicines 13/07/2015.
The future role of the Health & Social Care Network Rachel Quinn Chief Executive.
Federation for Healthcare Science (FHCS). Scientific/Technical/Therapy 10% NHS workforce data 2003: Total of 1.3M people employed 1.1M of these involved.
Mary Manning, Executive Director. Getting started The Academy of Medical Sciences: who we are Getting started on policy work Governance Selecting topics.
Health challenges in an enlarged Europe Report from Parallel Session A1 Dr. Natasha Azzopardi Muscat Ministry of Health - Malta.
From policy to practice and back to policy 3 March 2015 Children in Wales Conference Gail Bennett, Parenting Network Chair Flintshire Early Years and Family.
6 Key Priorities A “scorecard” for each of the 5 above priorities with end of 2009 deliverables – with a space beside each for a check mark (i.e. complete)
Procurement & Distribution Interest Group Symposium 10 th June 2010 Beth Loudon – Business Development Manager.
The Lancashire Skills and Employment Conversation #theskillsconversation.
Healthcare Scientists Leading Science in Health Jane Blower East Midlands SHA December 2011.
An Introduction to Genetic Alliance UK’s Work in Scotland Natalie Frankish – Development Officer for Scotland Event:Action Duchenne Scottish Conference.
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Webinar: FMLM GP Champions Network Dr Jane Povey, Deputy Medical Director, FMLM Wednesday 25 November 2015.
Royal Society of Chemistry Food Group Vision & Mission June 2015.
Educational Solutions for Workforce Development EDUCATION & DEVELOPMENT FRAMEWORK FOR SENIOR AHPs SUSAN SHANDLEY EDUCATIONAL PROJECTS MANAGER, AHP CAREERS.
Key Messages from the National Parenting Coordinators’ Network 10 September 2014 Gail Bennett, Parenting Network Chair Flintshire Parenting Strategy Coordinator.
NoWCADD Progress Report 2015
The Academy campaigns for the development, protection and promotion of careers for academics in the biomedical sciences and encourages good practice and.
Local Education and Training Boards Tim Gilpin Director of Workforce and Education NHS North of England.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Developing a Strategic Plan for the Future of the ACC ACC BOG Meeting | January 2014 Rick Chazal, MD, FACC.
PROFESSIONAL SERVICES DEVELOPMENT MANAGER - INITIAL STEPS HAMPSHIRE & ISLE OF WIGHT LOCAL PHARMACEUTICAL COMMITTEE Presentation by Richard Buxton 3 rd.
Growing a vibrant worldwide community of Scottish Country Dancers
Welsh Wound Network.
Business Development & Productivity Specialist Business Advisor
Aims: EVALSDGs seeks to: promote evaluation activities around the SDGs
Lunchtime Staff Meeting: Strategy development update – final stages
Update on development EBM Walnut Creek April 2017
Geriatric Medicine Society
KEYNOTE STAGE SPONSOR.
9th FIP AIM Global Dean’s Forum
Building a Digital Ready Workforce
Background to The Conference
Research for all Sharing good practice in research management
EXPLORING GLOBAL COOPERATION OPPORTUNITIES
Introduction to TransCelerate
CalSWEC 2014: Aging Initiative Summit
16 September 2010 Strategy Mark Dickinson, Director Planning and Performance Mark Dickinson, Director Planning and Performance.
FAST! An introduction
Royal Society of Chemistry Food Group
Presentation transcript:

Academy of Pharmaceutical Sciences John Wahlich, Jayne Lawrence, Eddie French

APS Mission and Aims Mission: Aims Championing innovation and opportunity in Pharmaceutical Sciences for the delivery of medicines Aims Promote the Pharmaceutical Sciences to stakeholders to facilitate understanding and achieve engagement Share learning, drive collaboration, partnership and innovation Deliver insights into industry and academic roles for emerging scientists

APS Strategic Themes The mission of the Academy of Pharmaceutical Sciences is to champion innovation and opportunity in Pharmaceutical Sciences for the delivery of medicines. Influence Policy More investment in Pharm Sciences in UK APS view sought by policy makers and TSB APS recognised as only professional group representing Pharm Sciences Senior Executives recognise the influence from and return on investment in APS Promote Careers Strengthen training and development of young scientists by supporting early career development Build APS membership amongst students Mentor post-grads and PhDs in academia Establish connection with TSB for research projects Further Scientific knowledge Support Focus Groups to further scientific knowledge Increase quantity of hard outputs/papers Influence direction of research funding Represent Pharma Sciences Establish APS reputation for balanced independent view of Pharm Sciences in UK Extend representation through engagement with pharma ‘mid tier’, CROs, CMOs and SMEs Increase membership amongst pharma scientist population APS Enablers Increase organisational membership Robust sponsorship income streams Clear APS brand definition

Current Chairperson(s) APS Focus Groups Focus Group Current Chairperson(s) Emerging Scientists and Development Helen Barker / Claire Thompson / Geoff Davison Biomolecules and Vaccines Kevin King Biopharmaceutics and oral drug delivery Mark McAllister Inhalation Eddie French Material Sciences Michael Leane Pharmacognosy Michael Heinrich Process Engineering, Product Formulation and Manufacturing Kendal Pitt Anti-infectives (Microbiology) Brendan Gilmore Skin Forum Majella Lane

APS The APS is a not-for-profit organisation funded through membership and sponsorship Of attendees today less than 25% are members of APS If you like what we’re doing and want to support the Pharmaceutical Sciences in the UK join the APS! £60 / year or £15 for students http://www.apsgb.co.uk/default.asp

Medicines for Older Adults Meeting Stevenage 13 March 2013 Medicines for older adults: Learning from practice to develop patient centric drug products Jointly organised by the Academy of Pharmaceutical Sciences (APS), the Geriatric Medicine Society and UCL School of Pharmacy The event created the platform to discuss the provision of medicines for older adults from a pharmaceutical sciences perspective Meeting commentary Int J Pharm. 2013 Nov 1;456(1):251-7. doi: 10.1016/j.ijpharm.2013.07.038. Epub 2013 Aug 3. (35 references)

Medicines for Older Adults ‘The use of medications in older patients is arguably the single most important health care intervention in the industrialized world’. (Avorn 2010) Meeting discussed Demographics of older adults Physiological aspects of ageing Medicines and ageing from a clinical, pharmacy and regulatory perspective ADRs, polypharmacy, adherence, formulation and delivery aspects Conclusion Parallels with paediatric medicines More could be done to improve the delivery of medicines to older adults Opportunity for collaboration to achieve this Avorn, J., 2010. Medication Use in Older Patients: Better Policy Could Encourage Better Practice. JAMA 304, 1606-1607.

Age Related Medicines Focus Group APS can provide the framework for collaboration Web site Access to membership and Linked-in contact networks Links with other Focus Groups Support (financial and organisational) for workshops / conferences / symposia APS Pharm Sci 2014 Conference September Potential for session at FIP Conference Bangkok (August 2014) Outcome from meeting Ownership going forward Committee identified Next steps agreed It’s your meeting we’re here to facilitate!